Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25


Dendritic Cell Dysfunction in Patients with End-stage Renal Disease.

Kim JU, Kim M, Kim S, Nguyen TT, Kim E, Lee S, Kim S, Kim H.

Immune Netw. 2017 Jun;17(3):152-162. doi: 10.4110/in.2017.17.3.152. Epub 2017 Jun 20. Review.


Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial.

Carvalho JTG, Schneider M, Cuppari L, Grabulosa CC, T Aoike D, Q Redublo BM, C Batista M, Cendoroglo M, Maria Moyses R, Dalboni MA.

PLoS One. 2017 Jun 30;12(6):e0179540. doi: 10.1371/journal.pone.0179540. eCollection 2017.


Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD).

Kim HY, Yoo TH, Hwang Y, Lee GH, Kim B, Jang J, Yu HT, Kim MC, Cho JY, Lee CJ, Kim HC, Park S, Lee WW.

Sci Rep. 2017 Jun 8;7(1):3057. doi: 10.1038/s41598-017-03130-z.


Effect of Different Dialysis Methods on Cellular Immunity Function of Maintenance Haemodialysis Patients.

Xing L.

West Indian Med J. 2015 Dec;64(5):499-505. doi: 10.7727/wimj.2016.178. Epub 2016 Apr 29.


Changes of immunogenic profiles between a single dose and one booster influenza vaccination in hemodialysis patients - an 18-week, open-label trial.

Chang YT, Wang JR, Lin MT, Wu CJ, Tsai MS, Wen-Chi CL, Shih TE, Kuo TH, Song EJ, Sung JM.

Sci Rep. 2016 Feb 12;6:20725. doi: 10.1038/srep20725.


End-stage renal disease (ESRD) contributes to the increasing prevalence of herpes zoster.

Sato T, Inoue T, Endo K, Watanabe Y, Kikuta T, Tsuda M, Arai J, Kobayashi K, Ikeda N, Ohno Y, Takenaka T, Suzuki H.

NDT Plus. 2009 Jun;2(3):263-4. doi: 10.1093/ndtplus/sfp024. No abstract available.


Hepatitis C in hemodialysis patients.

Marinaki S, Boletis JN, Sakellariou S, Delladetsima IK.

World J Hepatol. 2015 Mar 27;7(3):548-58. doi: 10.4254/wjh.v7.i3.548. Review.


Clinical relevance of procalcitonin and C-reactive protein as infection markers in renal impairment: a cross-sectional study.

Park JH, Kim DH, Jang HR, Kim MJ, Jung SH, Lee JE, Huh W, Kim YG, Kim DJ, Oh HY.

Crit Care. 2014 Nov 19;18(6):640. doi: 10.1186/s13054-014-0640-8.


Pediatric renal transplantation.

Saeed B.

Int J Organ Transplant Med. 2012;3(2):62-73. Review.


Biology of sepsis: its relevance to pediatric nephrology.

Blatt NB, Srinivasan S, Mottes T, Shanley MM, Shanley TP.

Pediatr Nephrol. 2014 Dec;29(12):2273-87. doi: 10.1007/s00467-013-2677-3. Epub 2014 Jan 10. Review.


Effectiveness of influenza vaccine in patients on hemodialysis--a review.

Mastalerz-Migas A, Gwiazda E, Brydak LB.

Med Sci Monit. 2013 Nov 18;19:1013-8. doi: 10.12659/MSM.889671. Review.


Periodontal disease: a covert source of inflammation in chronic kidney disease patients.

Ismail G, Dumitriu HT, Dumitriu AS, Ismail FB.

Int J Nephrol. 2013;2013:515796. doi: 10.1155/2013/515796. Epub 2013 Jun 6.


Impact of non-dialysis chronic kidney disease on survival in patients with septic shock.

Maizel J, Deransy R, Dehedin B, Secq E, Zogheib E, Lewandowski E, Tribouilloy C, Massy ZA, Choukroun G, Slama M.

BMC Nephrol. 2013 Apr 2;14:77. doi: 10.1186/1471-2369-14-77.


Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes.

Ichii H, Masuda Y, Hassanzadeh T, Saffarian M, Gollapudi S, Vaziri ND.

Am J Nephrol. 2012;36(1):50-7. doi: 10.1159/000339285. Epub 2012 Jun 19.


Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment.

McGrath LJ, Kshirsagar AV, Cole SR, Wang L, Weber DJ, Stürmer T, Brookhart MA.

Arch Intern Med. 2012 Apr 9;172(7):548-54. doi: 10.1001/archinternmed.2011.2238.


Effect of uremia on structure and function of immune system.

Vaziri ND, Pahl MV, Crum A, Norris K.

J Ren Nutr. 2012 Jan;22(1):149-56. doi: 10.1053/j.jrn.2011.10.020. Review.


The risk of infection-related hospitalization with decreased kidney function.

Dalrymple LS, Katz R, Kestenbaum B, de Boer IH, Fried L, Sarnak MJ, Shlipak MG.

Am J Kidney Dis. 2012 Mar;59(3):356-63. doi: 10.1053/j.ajkd.2011.07.012. Epub 2011 Sep 9.


Prevalence of clinical and subclinical thyroid disease in a peritoneal dialysis population.

Ng YY, Wu SC, Lin HD, Hu FH, Hou CC, Chou YY, Chiu SM, Sun YH, Cho SS, Yang WC.

Perit Dial Int. 2012 Jan-Feb;32(1):86-93. doi: 10.3747/pdi.2010.00202. Epub 2011 Apr 30.


Bidirectional relationship between chronic kidney and periodontal disease: a study using structural equation modeling.

Fisher MA, Taylor GW, West BT, McCarthy ET.

Kidney Int. 2011 Feb;79(3):347-55. doi: 10.1038/ki.2010.384. Epub 2010 Oct 6.


Effects of parathyroid hormone on immune function.

Geara AS, Castellanos MR, Bassil C, Schuller-Levis G, Park E, Smith M, Goldman M, Elsayegh S.

Clin Dev Immunol. 2010;2010. pii: 418695. doi: 10.1155/2010/418695. Epub 2010 Sep 16. Review.

Supplemental Content

Support Center